{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:30:07Z","timestamp":1777894207954,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BU 1141\/7-1 BU1141\/13-1"],"award-info":[{"award-number":["BU 1141\/7-1 BU1141\/13-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic steatohepatitis (NASH) is a rapidly growing liver disease. The chemoattractant chemerin is abundant in hepatocytes, and hepatocyte expressed prochemerin protected from NASH. Prochemerin is inactive and different active isoforms have been described. Here, the effect of hepatocyte expressed muChem-156, a highly active murine chemerin isoform, was studied in the methionine\u2013choline deficient dietary model of NASH. Mice overexpressing muChem-156 had higher hepatic chemerin protein. Serum chemerin levels and the capability of serum to activate the chemerin receptors was unchanged showing that the liver did not release active chemerin. Notably, activation of the chemerin receptors by hepatic vein blood did not increase in parallel to total chemerin protein in patients with liver cirrhosis. In experimental NASH, muChem-156 had no effect on liver lipids. Accordingly, overexpression of active chemerin in hepatocytes or treatment of hepatocytes with recombinant chemerin did not affect cellular triglyceride and cholesterol levels. Importantly, overexpression of muChem-156 in the murine liver did not change the hepatic expression of inflammatory and profibrotic genes. The downstream targets of chemerin such as p38 kinase were neither activated in the liver of muChem-156 producing mice nor in HepG2, Huh7 and Hepa1-6 cells overexpressing this isoform. Recombinant chemerin had no effect on global gene expression of primary human hepatocytes and hepatic stellate cells within 24\u00a0h of incubation. Phosphorylation of p38 kinase was, however, increased upon short-time incubation of HepG2 cells with chemerin. These findings show that muChem-156 overexpression in hepatocytes does not protect from liver steatosis and inflammation.<\/jats:p>","DOI":"10.1007\/s11010-022-04430-3","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T16:06:36Z","timestamp":1650557196000},"page":"2059-2071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis"],"prefix":"10.1007","volume":"477","author":[{"given":"Rebekka","family":"Pohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Eichelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Feder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Rein-Fischboeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichole","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Sinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Bruckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Wanninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"4430_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081649","author":"TE Adolph","year":"2017","unstructured":"Adolph TE, Grander C, Grabherr F, Tilg H (2017) Adipokines and non-alcoholic fatty liver disease: multiple interactions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18081649","journal-title":"Int J Mol Sci"},{"key":"4430_CR2","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3748\/wjg.v17.i23.2801","volume":"17","author":"C Buechler","year":"2011","unstructured":"Buechler C, Wanninger J, Neumeier M (2011) Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol 17:2801\u20132811. https:\/\/doi.org\/10.3748\/wjg.v17.i23.2801","journal-title":"World J Gastroenterol"},{"key":"4430_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"MM Yeh","year":"2014","unstructured":"Yeh MM, Brunt EM (2014) Pathological features of fatty liver disease. Gastroenterology 147:754\u2013764. https:\/\/doi.org\/10.1053\/j.gastro.2014.07.056","journal-title":"Gastroenterology"},{"key":"4430_CR4","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, Vos MB (2019) Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69:2672\u20132682. https:\/\/doi.org\/10.1002\/hep.30251","journal-title":"Hepatology"},{"key":"4430_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 46:32\u201336. https:\/\/doi.org\/10.1002\/hep.21669","journal-title":"Hepatology"},{"key":"4430_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1159\/000514953","volume":"39","author":"J Park","year":"2021","unstructured":"Park J, Lee EY, Li J, Jun MJ, Yoon E, Ahn SB, Liu C, Yang H, Rui F, Zou B, Henry L, Lee DH, Jun DW, Cheung RC, Nguyen MH (2021) NASH\/liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities: lessons from South Korea. Dig Dis 39:634\u2013645. https:\/\/doi.org\/10.1159\/000514953","journal-title":"Dig Dis"},{"key":"4430_CR7","doi-asserted-by":"publisher","first-page":"693507","DOI":"10.3389\/fmed.2021.693507","volume":"8","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zou X, Wen X, Zhou X, Ji L (2021) NAFLD or MAFLD: which has closer association with All-cause and cause-specific mortality?-Results from NHANES III. Front Med (Lausanne) 8:693507. https:\/\/doi.org\/10.3389\/fmed.2021.693507","journal-title":"Front Med (Lausanne)"},{"key":"4430_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G (2021) Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int 41:1290\u20131293. https:\/\/doi.org\/10.1111\/liv.14828","journal-title":"Liver Int"},{"key":"4430_CR9","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1210\/en.2007-0175","volume":"148","author":"K Bozaoglu","year":"2007","unstructured":"Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687\u20134694","journal-title":"Endocrinology"},{"key":"4430_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051128","author":"C Buechler","year":"2019","unstructured":"Buechler C, Feder S, Haberl EM, Aslanidis C (2019) Chemerin isoforms and activity in obesity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20051128","journal-title":"Int J Mol Sci"},{"key":"4430_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194778","author":"KB Goralski","year":"2019","unstructured":"Goralski KB, Jackson AE, McKeown BT, Sinal CJ (2019) More than an adipokine: the complex roles of chemerin signaling in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194778","journal-title":"Int J Mol Sci"},{"key":"4430_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153750","author":"O Treeck","year":"2019","unstructured":"Treeck O, Buechler C, Ortmann O (2019) Chemerin and cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20153750","journal-title":"Int J Mol Sci"},{"key":"4430_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","volume":"22","author":"B Bondue","year":"2011","unstructured":"Bondue B, Wittamer V, Parmentier M (2011) Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 22:331\u2013338. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.11.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"4430_CR14","doi-asserted-by":"publisher","first-page":"e0164179","DOI":"10.1371\/journal.pone.0164179","volume":"11","author":"O De Henau","year":"2016","unstructured":"De Henau O, Degroot GN, Imbault V, Robert V, De Poorter C, McHeik S, Gales C, Parmentier M, Springael JY (2016) Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2. PLoS ONE 11:e0164179. https:\/\/doi.org\/10.1371\/journal.pone.0164179","journal-title":"PLoS ONE"},{"key":"4430_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41416-018-0077-y","volume":"118","author":"JJ Li","year":"2018","unstructured":"Li JJ, Yin HK, Guan DX, Zhao JS, Feng YX, Deng YZ, Wang X, Li N, Wang XF, Cheng SQ, Bao Y, Xie D (2018) Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis. Br J Cancer 118:1337\u20131348. https:\/\/doi.org\/10.1038\/s41416-018-0077-y","journal-title":"Br J Cancer"},{"key":"4430_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/bs.mcb.2015.11.001","volume":"132","author":"S Dogra","year":"2016","unstructured":"Dogra S, Sona C, Kumar A, Yadav PN (2016) Tango assay for ligand-induced GPCR-beta-arrestin2 interaction: application in drug discovery. Methods Cell Biol 132:233\u2013254. https:\/\/doi.org\/10.1016\/bs.mcb.2015.11.001","journal-title":"Methods Cell Biol"},{"key":"4430_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2015.09.002","volume":"417","author":"JL Rourke","year":"2015","unstructured":"Rourke JL, Dranse HJ, Sinal CJ (2015) CMKLR1 and GPR1 mediate chemerin signaling through the RhoA\/ROCK pathway. Mol Cell Endocrinol 417:36\u201351. https:\/\/doi.org\/10.1016\/j.mce.2015.09.002","journal-title":"Mol Cell Endocrinol"},{"key":"4430_CR18","doi-asserted-by":"publisher","first-page":"28175","DOI":"10.1074\/jbc.M700793200","volume":"282","author":"KB Goralski","year":"2007","unstructured":"Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175\u201328188","journal-title":"J Biol Chem"},{"key":"4430_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/obr.12009","volume":"14","author":"JL Rourke","year":"2013","unstructured":"Rourke JL, Dranse HJ, Sinal CJ (2013) Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev 14:245\u2013262. https:\/\/doi.org\/10.1111\/obr.12009","journal-title":"Obes Rev"},{"key":"4430_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-1017","volume":"3","author":"C Buechler","year":"2014","unstructured":"Buechler C (2014) Chemerin in liver diseases. Endocrinol Metab Syndr 3:1\u20136. https:\/\/doi.org\/10.4172\/2161-1017","journal-title":"Endocrinol Metab Syndr"},{"key":"4430_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197205","author":"S Feder","year":"2020","unstructured":"Feder S, Bruckmann A, McMullen N, Sinal CJ, Buechler C (2020) Chemerin isoform-specific effects on hepatocyte migration and immune cell inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197205","journal-title":"Int J Mol Sci"},{"key":"4430_CR22","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1073\/pnas.0511167103","volume":"103","author":"NC Henderson","year":"2006","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ, Sethi T (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103:5060\u20135065. https:\/\/doi.org\/10.1073\/pnas.0511167103","journal-title":"Proc Natl Acad Sci USA"},{"key":"4430_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui AY, Albanis E, Arthur MJ, O\u2019Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54:142\u2013151. https:\/\/doi.org\/10.1136\/gut.2004.042127","journal-title":"Gut"},{"key":"4430_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207555","author":"M Spirk","year":"2020","unstructured":"Spirk M, Zimny S, Neumann M, McMullen N, Sinal CJ, Buechler C (2020) Chemerin-156 is the active isoform in human hepatic stellate cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207555","journal-title":"Int J Mol Sci"},{"key":"4430_CR25","doi-asserted-by":"publisher","first-page":"170422","DOI":"10.1016\/j.peptides.2020.170422","volume":"135","author":"X An","year":"2021","unstructured":"An X, Liu J, Li Y, Dou Z, Li N, Suo Y, Ma Y, Sun M, Tian Z, Xu L (2021) Chemerin\/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway. Peptides 135:170422. https:\/\/doi.org\/10.1016\/j.peptides.2020.170422","journal-title":"Peptides"},{"key":"4430_CR26","doi-asserted-by":"publisher","first-page":"119530","DOI":"10.1016\/j.lfs.2021.119530","volume":"278","author":"L Zhu","year":"2021","unstructured":"Zhu L, Huang J, Wang Y, Yang Z, Chen X (2021) Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1. Life Sci 278:119530. https:\/\/doi.org\/10.1016\/j.lfs.2021.119530","journal-title":"Life Sci"},{"key":"4430_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000282097","volume":"28","author":"JM Schattenberg","year":"2010","unstructured":"Schattenberg JM, Galle PR (2010) Animal models of non-alcoholic steatohepatitis: of mice and man. Dig Dis 28:247\u2013254","journal-title":"Dig Dis"},{"key":"4430_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010132","author":"R Pohl","year":"2022","unstructured":"Pohl R, Feder S, Haberl EM, Rein-Fischboeck L, Weiss TS, Spirk M, Bruckmann A, McMullen N, Sinal CJ, Buechler C (2022) Chemerin overexpression in the liver protects against inflammation in experimental non-alcoholic steatohepatitis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10010132","journal-title":"Biomedicines"},{"key":"4430_CR29","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1152\/ajpendo.00365.2018","volume":"316","author":"SR Nagarajan","year":"2019","unstructured":"Nagarajan SR, Paul-Heng M, Krycer JR, Fazakerley DJ, Sharland AF, Hoy AJ (2019) Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism. Am J Physiol Endocrinol Metab 316:E578\u2013E589. https:\/\/doi.org\/10.1152\/ajpendo.00365.2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4430_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","volume":"23","author":"CZ Larter","year":"2008","unstructured":"Larter CZ, Yeh MM (2008) Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 23:1635\u20131648. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05543.x","journal-title":"J Gastroenterol Hepatol"},{"key":"4430_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","volume":"95","author":"S Krautbauer","year":"2013","unstructured":"Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, Schmid A, Weiss TS, Dorn C, Buechler C (2013) Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp Mol Pathol 95:199\u2013205. https:\/\/doi.org\/10.1016\/j.yexmp.2013.07.009","journal-title":"Exp Mol Pathol"},{"key":"4430_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010252","author":"EM Haberl","year":"2019","unstructured":"Haberl EM, Pohl R, Rein-Fischboeck L, Feder S, Sinal CJ, Bruckmann A, Hoering M, Krautbauer S, Liebisch G, Buechler C (2019) Overexpression of hepatocyte chemerin-156 lowers tumor burden in a murine model of diethylnitrosamine-induced hepatocellular carcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21010252","journal-title":"Int J Mol Sci"},{"key":"4430_CR33","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1021\/acs.analchem.8b05013","volume":"91","author":"M Horing","year":"2019","unstructured":"Horing M, Ejsing CS, Hermansson M, Liebisch G (2019) Quantification of cholesterol and cholesteryl ester by direct flow injection high-resolution Fourier Transform mass spectrometry utilizing species-specific response factors. Anal Chem 91:3459\u20133466. https:\/\/doi.org\/10.1021\/acs.analchem.8b05013","journal-title":"Anal Chem"},{"key":"4430_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100050","author":"M Horing","year":"2021","unstructured":"Horing M, Ejsing CS, Krautbauer S, Ertl VM, Burkhardt R, Liebisch G (2021) Accurate quantification of lipid species affected by isobaric overlap in Fourier-Transform mass spectrometry. J Lipid Res. https:\/\/doi.org\/10.1016\/j.jlr.2021.100050","journal-title":"J Lipid Res"},{"key":"4430_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12944-019-1114-4","volume":"18","author":"L Rein-Fischboeck","year":"2019","unstructured":"Rein-Fischboeck L, Haberl EM, Pohl R, Feder S, Liebisch G, Krautbauer S, Buechler C (2019) Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities. Lipids Health Dis 18:172. https:\/\/doi.org\/10.1186\/s12944-019-1114-4","journal-title":"Lipids Health Dis"},{"key":"4430_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbalip.2018.02.006","volume":"1863","author":"L Rein-Fischboeck","year":"2018","unstructured":"Rein-Fischboeck L, Haberl EM, Pohl R, Schmid V, Feder S, Krautbauer S, Liebisch G, Buechler C (2018) Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. Biochim Biophys Acta Mol Cell Biol Lipids 1863:526\u2013537. https:\/\/doi.org\/10.1016\/j.bbalip.2018.02.006","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4430_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/en.2010-1157","volume":"152","author":"S Bauer","year":"2011","unstructured":"Bauer S, Wanninger J, Schmidhofer S, Weigert J, Neumeier M, Dorn C, Hellerbrand C, Zimara N, Schaffler A, Aslanidis C, Buechler C (2011) Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces Chemerin in hypertrophic adipocytes. Endocrinology 152:26\u201335","journal-title":"Endocrinology"},{"key":"4430_CR38","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.21873\/anticanres.12507","volume":"38","author":"EM Haberl","year":"2018","unstructured":"Haberl EM, Pohl R, Rein-Fischboeck L, Feder S, Sinal CJ, Buechler C (2018) Chemerin in a mouse model of non-alcoholic steatohepatitis and hepatocarcinogenesis. Anticancer Res 38:2649\u20132657. https:\/\/doi.org\/10.21873\/anticanres.12507","journal-title":"Anticancer Res"},{"key":"4430_CR39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12072-013-9475-7","volume":"7","author":"G Damm","year":"2013","unstructured":"Damm G, Pfeiffer E, Burkhardt B, Vermehren J, Nussler AK, Weiss TS (2013) Human parenchymal and non-parenchymal liver cell isolation, culture and characterization. Hepatol Int 7:951\u2013958. https:\/\/doi.org\/10.1007\/s12072-013-9475-7","journal-title":"Hepatol Int"},{"key":"4430_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-016-2926-4","volume":"428","author":"L Rein-Fischboeck","year":"2017","unstructured":"Rein-Fischboeck L, Pohl R, Haberl EM, Zimny S, Neumann M, Eisinger K, Weiss TS, Krautbauer S, Buechler C (2017) Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes. Mol Cell Biochem 428:161\u2013170. https:\/\/doi.org\/10.1007\/s11010-016-2926-4","journal-title":"Mol Cell Biochem"},{"key":"4430_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cyto.2018.02.004","volume":"104","author":"EM Haberl","year":"2018","unstructured":"Haberl EM, Pohl R, Rein-Fischboeck L, Feder S, Eisinger K, Krautbauer S, Sinal CJ, Buechler C (2018) Ex vivo analysis of serum chemerin activity in murine models of obesity. Cytokine 104:42\u201345. https:\/\/doi.org\/10.1016\/j.cyto.2018.02.004","journal-title":"Cytokine"},{"key":"4430_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","volume":"98","author":"K Eisinger","year":"2015","unstructured":"Eisinger K, Krautbauer S, Wiest R, Weiss TS, Buechler C (2015) Reduced serum chemerin in patients with more severe liver cirrhosis. Exp Mol Pathol 98:208\u2013213. https:\/\/doi.org\/10.1016\/j.yexmp.2015.01.010","journal-title":"Exp Mol Pathol"},{"key":"4430_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/labinvest.2014.3","volume":"94","author":"C Dorn","year":"2014","unstructured":"Dorn C, Engelmann JC, Saugspier M, Koch A, Hartmann A, Muller M, Spang R, Bosserhoff A, Hellerbrand C (2014) Increased expression of c-Jun in nonalcoholic fatty liver disease. Lab Invest 94:394\u2013408. https:\/\/doi.org\/10.1038\/labinvest.2014.3","journal-title":"Lab Invest"},{"key":"4430_CR44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.yexmp.2013.10.003","volume":"95","author":"S Krautbauer","year":"2013","unstructured":"Krautbauer S, Eisinger K, Lupke M, Wanninger J, Ruemmele P, Hader Y, Weiss TS, Buechler C (2013) Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. Exp Mol Pathol 95:330\u2013335. https:\/\/doi.org\/10.1016\/j.yexmp.2013.10.003","journal-title":"Exp Mol Pathol"},{"key":"4430_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, Zhang L (2016) TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem 64:157\u2013167. https:\/\/doi.org\/10.1369\/0022155415627681","journal-title":"J Histochem Cytochem"},{"key":"4430_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12944-020-01378-5","volume":"19","author":"J Jia","year":"2020","unstructured":"Jia J, Yu F, Xiong Y, Wei W, Ma H, Nisi F, Song X, Yang L, Wang D, Yuan G, Zhou H (2020) Chemerin enhances the adhesion and migration of human endothelial progenitor cells and increases lipid accumulation in mice with atherosclerosis. Lipids Health Dis 19:207. https:\/\/doi.org\/10.1186\/s12944-020-01378-5","journal-title":"Lipids Health Dis"},{"key":"4430_CR47","doi-asserted-by":"publisher","first-page":"e96345","DOI":"10.1371\/journal.pone.0096345","volume":"9","author":"N Gruben","year":"2014","unstructured":"Gruben N, Aparicio Vergara M, Kloosterhuis NJ, van der Molen H, Stoelwinder S, Youssef S, de Bruin A, Delsing DJ, Kuivenhoven JA, van de Sluis B, Hofker MH, Koonen DP (2014) Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic Fatty liver disease in mice. PLoS ONE 9:e96345. https:\/\/doi.org\/10.1371\/journal.pone.0096345","journal-title":"PLoS ONE"},{"key":"4430_CR48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1210\/en.2011-1490","volume":"153","author":"MC Ernst","year":"2012","unstructured":"Ernst MC, Haidl ID, Zuniga LA, Dranse HJ, Rourke JL, Zabel BA, Butcher EC, Sinal CJ (2012) Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 153:672\u2013682. https:\/\/doi.org\/10.1210\/en.2011-1490","journal-title":"Endocrinology"},{"key":"4430_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/JOE-14-0069","volume":"222","author":"JL Rourke","year":"2014","unstructured":"Rourke JL, Muruganandan S, Dranse HJ, McMullen NM, Sinal CJ (2014) Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice. J Endocrinol 222:201\u2013215. https:\/\/doi.org\/10.1530\/JOE-14-0069","journal-title":"J Endocrinol"},{"key":"4430_CR50","doi-asserted-by":"publisher","first-page":"158658","DOI":"10.1016\/j.bbalip.2020.158658","volume":"1865","author":"C Buechler","year":"2020","unstructured":"Buechler C, Aslanidis C (2020) Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158658. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158658","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4430_CR51","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13532","author":"PJ Gunn","year":"2017","unstructured":"Gunn PJ, Green CJ, Pramfalk C, Hodson L (2017) In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum. Physiol Rep. https:\/\/doi.org\/10.14814\/phy2.13532","journal-title":"Physiol Rep"},{"key":"4430_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105297","author":"EM Haberl","year":"2021","unstructured":"Haberl EM, Weiss TS, Peschel G, Weigand K, Kohler N, Pauling JK, Wenzel JJ, Horing M, Krautbauer S, Liebisch G, Buechler C (2021) Liver lipids of patients with hepatitis B and C and associated hepatocellular carcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105297","journal-title":"Int J Mol Sci"},{"key":"4430_CR53","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1038\/onc.2016.516","volume":"36","author":"Y Lin","year":"2017","unstructured":"Lin Y, Yang X, Liu W, Li B, Yin W, Shi Y, He R (2017) Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation. Oncogene 36:3599\u20133608. https:\/\/doi.org\/10.1038\/onc.2016.516","journal-title":"Oncogene"},{"key":"4430_CR54","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1039\/c8mt00099a","volume":"10","author":"P Sun","year":"2018","unstructured":"Sun P, Wang S, Wang J, Sun J, Peng M, Shi P (2018) The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells. Metallomics 10:838\u2013845. https:\/\/doi.org\/10.1039\/c8mt00099a","journal-title":"Metallomics"},{"key":"4430_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa084","author":"DJ Ferland","year":"2020","unstructured":"Ferland DJ, Mullick AE, Watts SW (2020) Chemerin as a driver of hypertension: a consideration. Am J Hypertens. https:\/\/doi.org\/10.1093\/ajh\/hpaa084","journal-title":"Am J Hypertens"},{"key":"4430_CR56","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1084\/jem.20071601","volume":"205","author":"JL Cash","year":"2008","unstructured":"Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 205:767\u2013775. https:\/\/doi.org\/10.1084\/jem.20071601","journal-title":"J Exp Med"},{"key":"4430_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.yexmp.2015.02.005","volume":"98","author":"R Pohl","year":"2015","unstructured":"Pohl R, Rein-Fischboeck L, Meier EM, Eisinger K, Krautbauer S, Buechler C (2015) Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Exp Mol Pathol 98:295\u2013299. https:\/\/doi.org\/10.1016\/j.yexmp.2015.02.005","journal-title":"Exp Mol Pathol"},{"key":"4430_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052350","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Dalbeni A (2021) Treatments for NAFLD: state of art. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22052350","journal-title":"Int J Mol Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04430-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:36:22Z","timestamp":1656333382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04430-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4430"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04430-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Experimental procedures using human tissues and cells accorded to the guidelines of the charitable state controlled foundation Human Tissue and Cell Research (Ethical vote number 12-101-0048). The protocol code for collecting blood of patients is 4\/99. Animal experiments were in accordance with the German Law on Animal Protection and the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals, 1999, and were approved by the University of Regensburg Laboratory Animal Committee (Government of Unterfranken, 55.2 DMS-2532-2-95).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}